3SBio licensed DJ5 patents from the Chinese Academy of Sciences' Shanghai Institute of Materia Medica to develop DJ5 for progressive renal failure in ADPKD patients

Chinese Academy of Sciences

China / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

3SBio Inc.

China / Small-Cap Biopharma (<$1 billion)

$367.8m on 05/24/2013 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced